News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,492 Results
Type
Article (39628)
Company Profile (247)
Press Release (657617)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204131)
Career Advice (2007)
Deals (35413)
Drug Delivery (95)
Drug Development (81031)
Employer Resources (172)
FDA (16171)
Job Trends (14851)
News (345121)
Policy (32525)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49408)
ALS (86)
Alzheimer's disease (1370)
Antibody-drug conjugate (ADC) (112)
Approvals (16173)
Artificial intelligence (242)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (267)
Cancer (2108)
Cardiovascular disease (168)
Career advice (1674)
Career pathing (29)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65854)
Collaboration (798)
Compensation (515)
Complete response letters (19)
COVID-19 (2582)
CRISPR (37)
C-suite (224)
Cystic fibrosis (100)
Data (2063)
Decentralized trials (2)
Denatured (17)
Depression (41)
Diabetes (259)
Diagnostics (6349)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86352)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111930)
Executive appointments (702)
FDA (17369)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (721)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (700)
Government (4407)
Grass and pollen (4)
Guidances (51)
Healthcare (18811)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (110)
Indications (27)
Infectious disease (2722)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16495)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7907)
Liver cancer (72)
Lung cancer (303)
Lymphoma (142)
Machine learning (5)
Management (58)
Manufacturing (288)
MASH (62)
Medical device (13348)
Medtech (13353)
Mergers & acquisitions (19437)
Metabolic disorders (660)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1877)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2547)
Now hiring (38)
Obesity (356)
Opinion (204)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (224)
Patient recruitment (102)
Peanut (46)
People (57222)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20508)
Phase II (28995)
Phase III (21615)
Pipeline (1116)
Policy (131)
Postmarket research (2563)
Preclinical (8677)
Press Release (64)
Prostate cancer (99)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (372)
Real estate (5906)
Recruiting (65)
Regulatory (22211)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (125)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2188)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (66)
Tariffs (27)
The Weekly (28)
United States (22134)
Vaccines (669)
Venture capitalists (38)
Weight loss (230)
Women's health (34)
Worklife (15)
Date
Today (115)
Last 7 days (442)
Last 30 days (2331)
Last 365 days (32826)
2025 (9390)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37769)
Australia (6178)
California (5814)
Canada (1947)
China (494)
Colorado (255)
Connecticut (264)
Delaware (136)
Europe (81039)
Florida (864)
Georgia (202)
Idaho (57)
Illinois (514)
India (25)
Indiana (302)
Iowa (10)
Japan (151)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (863)
Massachusetts (4352)
Michigan (216)
Minnesota (379)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1666)
New Mexico (28)
New York (1668)
North Carolina (942)
North Dakota (7)
Northern California (2547)
Ohio (195)
Oklahoma (14)
Oregon (33)
Pennsylvania (1311)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (20)
South Dakota (1)
Southern California (2188)
Tennessee (99)
Texas (865)
Utah (173)
Virginia (137)
Washington D.C. (60)
Washington State (535)
West Virginia (3)
Wisconsin (51)
697,492 Results for "pathmaker neurosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial
PathMaker Neurosystems Inc. announced that it has received a funding award of $2.16 million from the Congressionally Directed Medical Research Program at the United States Department of Defense’s U.S. Army Medical Research and Development Command, as part of its FY23 Amyotrophic Lateral Sclerosis Research Program Pilot Clinical Trial Award.
June 5, 2024
·
4 min read
Genetown
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
PathMaker Neurosystems Inc. announced the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis.
September 14, 2023
·
3 min read
Genetown
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
PathMaker Neurosystems Inc. was selected as one of five companies in Massachusetts to receive a START Stage 2 award from MassVentures, which funds deep tech startups based in Massachusetts as they advance technology developed under SBIR/STTR grant funding.
June 5, 2023
·
2 min read
Business
Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
The Muscular Dystrophy Association (MDA) and PathMaker Neurosystems Inc. announced today an investment of $600,000 through the MDA Venture Philanthropy (MVP) program to PathMaker to advance its work in amyotrophic lateral sclerosis (ALS).
January 17, 2023
·
4 min read
Genetown
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
PathMaker Neurosystems Inc., a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, was selected as a recipient of a START award from MassVentures, which funds deep tech startups based in Massachusetts as they advance technology developed under NIH SBIR/STTR funding.
June 8, 2022
·
2 min read
Genetown
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. announced that it was awarded a CERF Medical Electronics Prize from the Cullen Education and Research Fund, a private philanthropy based in London, United Kingdom.
February 7, 2022
·
3 min read
Genetown
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
PathMaker Neurosystems Inc. announced initiation of its U.S. multi-center clinical trial to evaluate MyoRegulator® for the non-invasive treatment of post-stroke upper-limb spasticity.
March 7, 2022
·
4 min read
Business
PathMaker Neurosystems Appoints Veteran Healthcare Investor William Mills to Board of Directors
PathMaker Neurosystems Inc. has named William C. Mills, to the Company’s Board of Directors.
May 29, 2019
·
2 min read
Genetown
PathMaker Neurosystems is Named as Recipient of France’s Top Prize for Innovation
PathMaker Neurosystems Inc., a clinical-stage bioelectronic medicine company developing breakthrough non-invasive systems for the treatment of patients with spasticity and paralysis, is very pleased to announce that it has been named as the 2019 recipient of the CCI France International Trophy for Innovation at this year’s Trophées CCI France International.
June 26, 2019
·
3 min read
Genetown
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator® Device for Non-Invasive Treatment of Spasticity
PathMaker Neurosystems Inc., a clinical-stage bioelectronic medicine company developing breakthrough non-invasive systems for the treatment of patients with spasticity and paralysis announces the first publication of clinical trial results for its MyoRegulator® device for the non-invasive treatment of spasticity.
July 25, 2019
·
4 min read
1 of 69,750
Next
